5 Biggest Price Target Changes For Tuesday

By: via Benzinga
Leerink Partners lowered the price target on Intra-Cellular Therapies Inc (NASDAQ: ITCI) from $29 to $10. Intra-Cellular ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.